Compare Unichem Lab with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ALEMBIC PHARMA UNICHEM LAB/
ALEMBIC PHARMA
 
P/E (TTM) x -47.7 17.5 - View Chart
P/BV x 1.2 7.0 16.8% View Chart
Dividend Yield % 1.2 0.5 215.8%  

Financials

 UNICHEM LAB   ALEMBIC PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
ALEMBIC PHARMA
Mar-19
UNICHEM LAB/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs292664 44.0%   
Low Rs182412 44.1%   
Sales per share (Unadj.) Rs167.7208.7 80.3%  
Earnings per share (Unadj.) Rs-3.631.0 -11.7%  
Cash flow per share (Unadj.) Rs5.937.1 16.0%  
Dividends per share (Unadj.) Rs4.005.50 72.7%  
Dividend yield (eoy) %1.71.0 165.2%  
Book value per share (Unadj.) Rs372.3144.2 258.1%  
Shares outstanding (eoy) m70.38188.52 37.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.42.6 54.8%   
Avg P/E ratio x-65.317.4 -376.0%  
P/CF ratio (eoy) x39.914.5 275.0%  
Price / Book Value ratio x0.63.7 17.1%  
Dividend payout %-110.217.7 -620.9%   
Avg Mkt Cap Rs m16,680101,461 16.4%   
No. of employees `0002.6NA-   
Total wages/salary Rs m2,3937,467 32.1%   
Avg. sales/employee Rs Th4,535.2NM-  
Avg. wages/employee Rs Th919.8NM-  
Avg. net profit/employee Rs Th-98.2NM-  
INCOME DATA
Net Sales Rs m11,80139,347 30.0%  
Other income Rs m98494 1,049.1%   
Total revenues Rs m12,78539,441 32.4%   
Gross profit Rs m-8358,736 -9.6%  
Depreciation Rs m6741,152 58.5%   
Interest Rs m75184 40.8%   
Profit before tax Rs m-6007,493 -8.0%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m1-93 -0.8%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3431,568 -21.9%   
Profit after tax Rs m-2565,844 -4.4%  
Gross profit margin %-7.122.2 -31.9%  
Effective tax rate %57.320.9 273.8%   
Net profit margin %-2.214.9 -14.6%  
BALANCE SHEET DATA
Current assets Rs m20,38419,577 104.1%   
Current liabilities Rs m5,02914,896 33.8%   
Net working cap to sales %130.111.9 1,093.7%  
Current ratio x4.11.3 308.4%  
Inventory Days Days10590 116.7%  
Debtors Days Days13545 297.4%  
Net fixed assets Rs m9,02327,097 33.3%   
Share capital Rs m141377 37.3%   
"Free" reserves Rs m26,05826,811 97.2%   
Net worth Rs m26,19927,188 96.4%   
Long term debt Rs m04,993 0.0%   
Total assets Rs m31,49647,778 65.9%  
Interest coverage x-7.041.7 -16.7%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.40.8 45.5%   
Return on assets %-0.612.6 -4.5%  
Return on equity %-1.021.5 -4.5%  
Return on capital %-2.023.6 -8.5%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18819,453 42.1%   
Fx outflow Rs m5966,065 9.8%   
Net fx Rs m7,59213,388 56.7%   
CASH FLOW
From Operations Rs m-3,2788,120 -40.4%  
From Investments Rs m-2,860-7,556 37.9%  
From Financial Activity Rs m-24590 -4.1%  
Net Cashflow Rs m-4,6901,153 -406.7%  

Share Holding

Indian Promoters % 50.1 74.1 67.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 2.9 520.7%  
FIIs % 3.0 9.1 33.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 13.9 228.1%  
Shareholders   20,176 49,328 40.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   FULFORD INDIA  AUROBINDO PHARMA  STERLING BIOTECH  WOCKHARDT  SUN PHARMA  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Lower Oxygen Supplies to Affect 5 Sectors, Tata Steel's Blockchain Transaction, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note yesterday. At the closing bell yesterday, the BSE Sensex stood higher by 375 points (up 0.8%).

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4% (Quarterly Result Update)

Aug 21, 2019 | Updated on Aug 21, 2019

For the quarter ended June 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 36.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.0% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Apr 22, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS